Otonomy to Participate in Three Upcoming Investor Conferences
February 25 2021 - 7:30AM
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced that management will participate in
three upcoming virtual conferences:
- A fireside chat at the Cowen 41st
Annual Health Care Conference on March 4, 2021 at 12:50 p.m. ET /
9:50 a.m. PT;
- A pre-recorded presentation at the
H.C. Wainwright Global Life Sciences Conference available on-demand
starting at 7 a.m. ET / 4 a.m. PT on March 9, 2021; and
- A presentation at the Oppenheimer
31st Annual Healthcare Conference on March 16, 2021 at 11:20 a.m.
ET / 8:20 a.m. PT.
Live audio webcasts will be available through the Events page of
the company's website (www.otonomy.com).
About OtonomyOtonomy is a biopharmaceutical
company dedicated to the development of innovative therapeutics for
neurotology. The company pioneered the application of drug delivery
technology to the ear in order to develop products that achieve
sustained drug exposure from a single local administration. This
approach is covered by a broad patent estate and is being utilized
to develop a pipeline of products addressing important unmet
medical needs including Ménière’s disease, hearing loss, and
tinnitus. For additional information, please visit
www.otonomy.com.
Contacts:
Media InquiriesSpectrum ScienceChloé-Anne RamseyVice
President404.865.3601cramsey@spectrumscience.com
Investor InquiriesWestwicke ICRRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Apr 2023 to Apr 2024